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Abstract 
New six fluorescent 1,3-diarylureas linked by C-C Suzuki coupling to the 6-position of the methyl 
3-aminothieno[3,2-b]pyridine-2-carboxylate moiety were prepared by reaction of the amino groups on 
the ortho or meta positions relative to the C-C bond of the Suzuki coupling products, with different 
para-substituted arylisocyanates (H, OMe, CN), in high to excellent yields. The fluorescence 
properties of the 1,3-diarylureas in solution and in lipid membranes of egg-yolk phosphatidylcholine 
(Egg-PC), dipalmitoyl phosphatidylcholine (DPPC), dipalmitoyl phosphatidylglycerol (DPPG) or 
dioctadecyldimethylammonium bromide (DODAB), with or without cholesterol (Ch), were studied. 
The six 1,3-diarylureas have reasonable fluorescence quantum yields in several solvents (0.02  F  
0.69) and present a moderately solvent sensitive emission, but are not fluorescent in alcohols and 
water. The compounds bearing the arylurea moiety in the meta position relative to the C-C bond, 
especially with the OMe and CN substituents, present the better solvatochromic properties.   
Incorporation of the six compounds in lipid membranes indicates that all the compounds are deeply 
located in the hydrophobic region of the lipid bilayers, feeling the transition between the rigid gel 
phase and fluid phases.  
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1. Introduction 
Unsymmetrical 1,3-diarylureas have attracted much attention due to their diverse 
applications in agriculture, medicine, petrochemicals, supramolecular chemistry (anion 
receptors), biology and as important intermediates and bifunctional organocatalysts in organic 
synthesis [1-3]. 
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Thienopyridines including their 1,3-diarylurea derivatives have shown different biological 
activities, namely as antitumoral agents [4] and receptor tyrosine kinase inhibitors [5].  
In this work, six new 1,3-diarylureas were prepared by reaction of aminated compounds, 
resulting from Suzuki coupling of methyl 3-amino-6-bromothieno[3,2-b]pyridine-2-
carboxylate and ortho or meta pinacolborane ester anilines [6], with different para-substituted 
arylisocyanates (H, OMe, CN).  
Due to the potential biological activity of the new compounds, their interaction with lipid 
membranes is of particular interest. The photophysical properties of these thieno[3,2-
b]pyridine 1,3-diarylurea derivatives in solution and in lipid bilayers were studied. Lipid 
membranes were composed of neutral/zwitterionic phospholipids (DPPC – dipalmitoyl 
phosphatidylcholine; Egg-PC – egg yolk phosphatidylcholine), anionic phospholipids (DPPG  
– dipalmitoyl phosphatidylglycerol) or synthetic cationic lipids (DODAB – 
dioctadecyldimethylammonium bromide). The incorporation of cholesterol, an important 
component of most natural membranes, may increase the stability of the lipid aggregates by 
modulating the fluidity of the lipid bilayer, preventing crystallization of the phospholipid acyl 
chains and providing steric hindrance to their movement [7]. 
Fluorescence anisotropy measurements can give relevant information about the compounds 
behavior and location in the lipid membranes, namely if they are located deeply in the lipid 
bilayer, feeling the differences between the rigid gel phase and the fluid liquid-crystalline 
phase of the lipids.  
 
 
2. Experimental 
2.1. Synthesis 
 
2.1.1.General Remarks 
  
Melting points (ºC) were determined in a SMP3 Stuart apparatus and are uncorrected.
 1
H and 
13
C NMR spectra were recorded on a Bruker Avance III at 400 and 100.6 MHz or on a Varian 
Unity Plus at 300 and 75.4 MHz, respectively. Heteronuclear correlations, 
1
H-
13
C, HMQC or 
HSQC were performed to attribute some signals.  
HRMS data were recorded using a method of direct injection by ESI-TOF by the mass 
spectrometry service of the University of Vigo, Spain.  
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The reactions were monitored by thin layer chromatography (TLC) in aluminium plates 
covered with a layer of silica gel 60 (Macherey-Nagel) of 0.2 mm, with UV254 fluorescence 
indicator.  
 
2.1.2. General procedure for the synthesis of 1,3-diarylureas (Scheme 1): Compounds 1a-b
 
[6] and different arylisocyanates (1 equiv.) in 6 mL CH2Cl2: THF (1:1) were left stirring  at 
room temperature for 16 h. If a precipitate didn’t come out after this time, hexane (3-5 mL) 
was added to the mixture to precipate the product. This was filtered under vacuum to give the 
corresponding 1,3-diarylureas. 
 
2.1.2.1. Methyl 3-amino-6-[3-(3-phenylureido)phenyl]thieno[3,2-b]pyridine-2-carboxylate 
(2a): From compound 1a (80.0 mg, 0.270 mmol) and phenylisocyanate (32.0 mg) compound 
2a was isolated as a yellow solid (100 mg, 90%), m.p. 226-226.5 ºC. 
1
H NMR (400 MHz, 
DMSO-d6): δ  3.83 (3H, s, OMe), 6.93 (2H, br s, NH2), 6.95-6.99 (1H, m, ArH), 7.26-7.30 
(2H, m, ArH), 7.40-7.52 (5H, m, ArH), 7.91 (1H, broad s, 2’-H), 8.62 (1H, d, J = 2Hz, 7-H), 
8.75 (1H, br s, NH), 8.82 (1H, br s, NH), 8.93 (1H, d, J = 2 Hz, 5-H) ppm. 
13
C NMR (400 
MHz, DMSO-d6): δ 51.5 (OMe), 97.4 (C), 117.0 (2’-CH), 118.3 (2CH) 118.4 (CH), 121.0 
(CH), 121.9 (CH), 128.8 (2×CH), 129.3 (7-CH), 129.7 (CH), 133.9 (C), 135.1 (C), 137.3 (C), 
139.6 (C), 140.5 (C), 145.4 (C), 145.5 (5-CH), 147.9 (C), 152.6 (C=O), 164.6 (C=O) ppm. 
HRMS (ESI-TOF) Calcd. for C22H19N4O4S [M+H]
+
 419.1172; found 419.1188. 
 
2.1.2.2. Methyl 3-amino-6-{3-[3-(4-methoxyphenyl)ureido]phenyl}thieno[3,2-b]pyridine-2-
carboxylate (2b): From compound 1a (150 mg, 0.540 mmol) and 4-methoxyphenylisocyanate 
(80.0 mg) compound 2b was isolated as a yellow solid (217 mg, 90%), m.p. 243-244 ºC. 
1
H 
NMR (400 MHz, DMSO-d6): δ  3.71 (s, 3H, OMe), 3.83 (s, 3H, OMe), 6.87 (2H, d, J = 9.2 
Hz, 3’’ and 5’’-H), 6.93 (2H, br s, NH2), 7.36 (2H, d, J = 9.2 Hz, 2’’ and 6’’-H), 7.38-7.50 
(3H, m, ArH), 7.89 (1H, br s, 2’-H), 8.55 (1H,  br s, NH), 8.61 (1H, d, J = 2.0 Hz, 7-H), 8.73 
(1H, broad s, NH), 8.92 (1H, d, J = 2.0 Hz, 5-H) ppm. 
13
C NMR (100.6 MHz, DMSO-d6): δ  
51.6 (OMe), 55.2 (OMe), 97.4 (C), 114.0 (3’’and 5’’-CH), 116.9 (2’-CH), 118.3 (CH), 120.2 
(2’’and 6’’-CH), 120.8 (CH), 129.3 (7-CH), 129.7 (CH), 132.6 (C), 133.9 (C), 135.2 (C), 
137.3 (C), 140.7 (C), 145.4 (C), 145.5 (5-CH), 147.9 (C), 152.8 (C=O), 154.6 (C), 164.6 
(C=O) ppm. HRMS (ESI-TOF) Calcd. for C23H21N4O4S [M+H]
+ 
449.1284; found 449.1284. 
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2.1.2.3. Methyl 3-amino-6-{3-[3-(4-cyanophenyl)ureido]phenyl}thieno[3,2-b]pyridine-2-
carboxylate (2c): From compound 1a (100 mg, 0.330 mmol) and 4-cyanophenylisocyanate 
(50.0 mg) compound 2c was isolated as a yellow solid (120 mg, 80%), m.p. 264-265 ºC. 
1
H 
NMR (300 MHz, DMSO-d6): δ 3.83 (3H, s, OMe), 6.94 (2H, br s, NH2), 7.45-7.47 (2H, m, 
ArH), 7.49-7.54 (1H, m, ArH), 7.65 (2H, d, J = 9.0 Hz, 2’’ and 6’’-H), 7.73 (2H, d, J = 9.0 
Hz, 3’’ and 5’’-H), 7.90 (1H, br s, 2’-H), 8.62 (1H, d, J = 2 Hz, 7-H), 8.92 (1H, d, J = 2.0 Hz, 
5-H), 9.01 (1H, br s, NH), 9.30 (1H, br s, NH) ppm. 
13
C NMR (75.4 MHz, DMSO-d6): δ   
51.6 (OMe), 97.4 (C), 103.4 (C), 117.4 (2’-CH) 118.1 (2’’ and 6’’-CH), 118.7 (CH) 119.3 
(C), 121.5 (CH), 129.4 (7-CH), 129.8 (CH), 133.3 (3’’ and 5’’-CH), 133.9 (C), 135.0 (C), 
137.4 (C), 140.0 (C), 144.1 (C), 145.5 (C), 145.6 (5-CH), 147.9 (C), 152.2 (C=O), 164.6 
(C=O) ppm. HRMS (ESI-TOF) Calcd. for C23H18N5O3S [M+H]
+ 
444.1125; found 444.1120. 
 
2.1.2.4. Methyl 3-amino-6-[2-(3-phenylureido)phenyl]thieno[3,2-b]pyridine-2-carboxylate 
(3a): From compound 1b (125 mg, 0.420 mmol) and phenylisocyanate (50.0 mg) compound 
3a was isolated as a yellow solid (120 mg, 75%), m.p. 226-227 ºC. 
1
H NMR (400 MHz, 
DMSO-d6): δ  3.83 (3H, s, OMe), 6.91-6.95 (m, 1H, ArH), 6.97 (2H, br s, NH2), 7.17-7.25 
(3H, m, ArH), 7.35-7.44 (4H, m, ArH), 7.86 (1H, br  s, NH), 8.00  (1H, dd, J = 8.0 and 1.2 
Hz, ArH), 8.43 (1H, d, J = 2 Hz, 7-H), 8.65 (1H, d, J = 2 Hz, 5-H), 8.79 (1H, br s, NH) ppm. 
13
C NMR (100.6 MHz, DMSO-d6): δ  51.6 (OMe), 97.3 (C), 118.0 (2×CH), 121.8 (CH), 
122.6 (CH) 123.5 (CH), 128.8 (2×CH) 128.9 (CH), 129.1 (C), 130.7 (CH), 132.1 (7-CH), 
133.7 (C), 133.8 (C), 136.5 (C), 139.6 (C), 145.3 (C), 147.3 (5-CH), 148.0 (C), 152.6 (C=O), 
164.6 (C=O) ppm. HRMS (ESI-TOF) Calcd. for C22H19N4O3S [M+H]
 +
 419.1172; found 
419.1180. 
 
2.1.2.5. Methyl 3-amino-6-{2-[3-(4-methoxyphenyl)ureido]phenyl}thieno[3,2-b]pyridine-2-
carboxylate (3b): From compound 1b (100 mg, 0.330 mmol)  with 4-
methoxyphenylisocyanate (50.0 mg) compound 3b was obtained (100 mg, 70%), m.p. 243-
244 ºC. 
1
H NMR (400 MHz, DMSO-d6): δ  3.68 (3H, s, OMe), 3.83 (3H, s, OMe), 6.81 (2H, 
d, J = 9.2 Hz, 3” and 5”- H), 6.97 (2H, br s, NH2), 7.15-7.19 (1H, m, ArH), 7.25 (2H, d, J = 
9.2 Hz, 2” and 6”-H), 7.32-7.35 (1H, m, ArH), 7.38-7.42 (1H, m, ArH), 7.77 (1H, br s, NH), 
7.99 (1H, br d, J = 8.4 Hz, ArH), 8.42 (1H, d, J = 2.0 Hz, 7-H), 8.63 (1H, br s, NH), 8.64 (1H, 
d, J = 2.0 Hz, 5-H). 
13
C (100.6 MHz, DMSO-d6): δ 51.6 (OMe), 55.1 (OMe), 97.2 (C), 99.7 
(C), 114.0 (3’’ and 5’’-CH), 119.8 (2’’and 6’’-CH), 122.3 (CH), 123.2 (CH) 128.9 (CH), 
130.7 (CH), 132.1 (7-CH), 132.6 (C), 133.8 (C), 136.7 (C), 145.3 (C), 147.3 (5-CH), 148.0 
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(C), 152.7 (C=O), 154.4 (C), 164.6 (C=O) ppm. HRMS (ESI-TOF) Calcd. for C23H21N4O4S 
[M+H]
+ 
449.1284; found  449.1280. 
 
2.1.2.6. Methyl 3-amino-6-{2-[3-(4-cyanophenyl)ureido]phenyl}thieno[3,2-b]pyridine-2-
carboxylate (3c): From compound 1b (140 mg, 0.470 mmol) and 4-cyanophenylisocyanate 
(69.0 mg) compound 3c was isolated as a yellow solid (120 mg, 75%), m.p. 210-211 ºC. 
1
H 
NMR (400 MHz, DMSO-d6): δ  3.83 (3H, s, OMe), 6.96 (2H, br s, NH2), 7.22-7.26 (1H, m, 
ArH), 7.36-7.39 (1H, m, ArH), 7.52-7.55 (1H, m, ArH), 7.53 (2H, d, J = 8.8 Hz, 2’’ and 6’’-
H), 7.67 (2H, d, J = 8.8 Hz, 3’’ and 5’’-H), 7.93-7.95 (1H, m, ArH), 8.07 (1H, br s, NH), 8.44 
(1H, d, J = 2 Hz, 7-H), 8.65 (1H, d, J = 2.0 Hz, 5-H), 9.28 (1H, br s, NH) ppm. 
13
C NMR 
(100.6 MHz, DMSO-d6): δ  51.6 (OMe), 97.3 (C), 103.3 (C), 117.9 (2’’ and 6’’-CH), 119.3 
(C) 123.2 (CH), 124.2 (CH) 129.0 (CH), 129.8 (C), 130.8 (CH), 132.1 (7-CH), 133.3 (3’’ and 
5’’-CH), 133.6 (C), 133.7 (C), 135.8 (C), 144.1 (C), 145.3 (C), 147.2 (5-CH), 147.9 (C), 
152.3 (C=O), 164.6 (C=O) ppm. HRMS (ESI-TOF) Calcd. for C23H18N5O3S [M+H]
+ 
444.1125; found 444.1129. 
 
2.2. Lipid membranes preparation 
All the solutions were prepared using spectroscopic grade solvents and ultrapure water (Milli-
Q grade). 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-diacyl-sn-glycero-3-
phosphocholine from egg yolk (egg-PC), 1,2-dipalmitoyl-sn-glycero-3-[phospho-rac-(1-
glycerol)] (sodium salt) (DPPG) and cholesterol were obtained from Sigma-Aldrich and 
dioctadecyldimethylammonium bromide (DODAB) from Tokyo Kasei (lipid structures are 
shown below). 
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For lipid vesicles preparation, the ethanolic injection method was used [8-10]. For egg-PC 
membranes preparation, defined volume of stock solution of lipid (86.2 mM) and each 
compound (0.3 mM) in ethanol were injected together, under vigorous stirring, to an aqueous 
buffer solution (10 mM Tris, pH=7.4), at room temperature. A similar procedure was adopted 
for DPPC, DODAB and DPPG vesicles, but the injection of the required amounts of stock 
solutions of lipid (50 mM for DPPC, 20 mM for DODAB and 26.8 mM for DPPG) and 
compounds in ethanol was done at 60 ºC, well above the melting transition temperature of 
each lipid (ca. 41 ºC for DPPC [11], ca. 45 ºC for DODAB [12], and 39.6 ºC for DPPG [13]). 
In all cases, the final lipid concentration was 1 mM, with a compound/lipid molar ratio of 
1:333. 
 
2.3. Spectroscopic measurements 
 Absorption spectra were recorded in a Shimadzu UV-3101PC UV-Vis-NIR 
spectrophotometer. Fluorescence measurements were performed using a Fluorolog 3 
spectrofluorimeter, equipped with double monochromators in both excitation and emission, 
Glan-Thompson polarizers and a temperature controlled cuvette holder.  Fluorescence spectra 
were corrected for the instrumental response of the system.  
For fluorescence quantum yield determination, the solutions were previously bubbled for 
20 minutes with ultrapure nitrogen. The fluorescence quantum yields (s) were determined 
using the standard method (equation 1) [14,15]. Quinine sulfate in H2SO4 0.05 M was used as 
reference, r = 0.546 at 25 ºC [16]. 
         r2rrs2ssrs  nFAnFA      (1) 
where A is the absorbance at the excitation wavelength, F the integrated emission area and n 
the refraction index of the solvents used. Subscripts refer to the reference (r) or sample (s) 
compound. The absorbance value at excitation wavelength was always less than 0.1, in order 
to avoid inner filter effects. 
Solvatochromic shifts can be described by the Lippert-Mataga equation (2), which relates 
the energy difference between absorption and emission maxima to the orientation 
polarizability, [17,18] 
constf
hcR




3
2
flabs
2
4
1
0
          (2) 
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where abs  is the wavenumber of maximum absorption, fl  is the wavenumber of maximum 
emission,  = e – g is the difference in the dipole moment of solute molecule between 
excited (e) and ground (g) states, R is the cavity radius (considering the fluorophore a point 
dipole at the center of a spherical cavity immersed in the homogeneous solvent), and f  is 
the orientation polarizability given by (eq. 3): 
12
1
12
1
2
2






n
n
f   ,            (3)  
where  is the static dielectric constant and n the refractive index of the solvent.  
An alternative expression, proposed by Bakhshiev, takes into account the angle, , between 
the ground and excited state dipole moments of the fluorophore [19,20]:   
    constnf
hcR


 ,cos2
2
4
1 2
eeg
2
g3flabs
0
  (4) 
where 2eeg
2
g cos2   is equivalent to 
2
ge 

 and 
   
2
1
2
1
,
2
2





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n
n
nf       (5) 
The steady-state fluorescence anisotropy, r, is calculated by 
          
VHVV
VHVV
2 IGI
IGI
r


             (6) 
where IVV and IVH are the intensities of the emission spectra obtained with vertical and 
horizontal polarization, respectively (for vertically polarized excitation light), and 
HHHV IIG   is the instrument correction factor, where IHV and IHH are the emission 
intensities obtained with vertical and horizontal polarization (for horizontally polarized 
excitation light). 
 
3. Results and discussion 
 
3.1. Synthesis 
New 1,3-diarylureas 2a-c  and 3a-c were prepared by reaction of the aromatic amino groups 
of the Suzuki coupling products 1a-b, earlier obtained by us from methyl 3-amino-6-
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bromothieno[3,2-b]pyridine-2-carboxylate and pinacolborane esters of anilines [6], with 
arylisocyanates, in high to excellent yields (Scheme 1). 
N
S
NH2
CO2Me
N
C
O
CH2Cl2/THF
rt, 16h
R2
1a R1 =NH2, R
2 =H 
1b R2 =NH2, R
1 = H
R3 = H, OMe or CN
N
S
NH2
CO2Me
NH
HN O
R3
3a R3 = H, 75%
3b R3 = OMe, 70%
3c R3 = CN, 75%
R1
N
S
NH2
CO2Me
HN
HN
O
R3
R3
2a R3 = H, 90%
2b R3 = OMe, 90%
2c R3 = CN, 80%
 
Scheme 1. Synthesis of 1,3-diarylureas 2-3 derivatives of thieno[3,2-b]pyridines by reaction of 
anilines with arylisocyanates. 
 
 
 
3.2. Fluorescence studies in several solvents 
The absorption and fluorescence properties of compounds 2a-c and 3a-c were studied in 
several solvents (Table SD1 in Supplementary Data). The normalized fluorescence spectra of 
compounds 2a, 2c and 3b are shown in Figures 1, 2 and 3, respectively (examples of 
absorption spectra are also shown as insets).  
Compounds 2a-c and 3a-c exhibit reasonable fluorescence emission in several solvents (the 
studied solvents do not include cyclo- or n-alkanes, because the solubility of these compounds 
is very poor in this kind of solvents). Fluorescence quantum yield values are in the range of 
6% in chloroform and 65% in DMSO for compounds 2a-c and of 2% (chloroform) and 69% 
(DMSO) for compounds 3a-c (Table SD1). However, no emission is observed in protic 
solvents like water, methanol or ethanol.  
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Figure 1. Normalized fluorescence spectra of 310-6 M solutions of compound 2a in several solvents 
(exc=370 nm). Inset: Absorption spectrum of 10
-5
 M solutions of 2a in dioxane and acetonitrile, as 
examples. 
 
Figure 2. Normalized fluorescence spectra of 310-6 M solutions of compound 2c in several solvents 
(exc=370 nm). Inset: Absorption spectrum of 10
-5
 M solutions of 2c in dioxane and acetonitrile, as 
examples. 
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Figure 3. Normalized fluorescence spectra of 310-6 M solutions of compound 3b in several solvents 
(exc=370 nm). Inset: Absorption spectrum of 10
-5
 M solutions of 3b in dioxane and acetonitrile, as 
examples. 
 
 
This behavior, already observed for di(hetero)arylether derivatives of thieno[3,2-b]pyridines 
recently synthesized [21], can be due to specific solute-solvent interactions by hydrogen 
bonds with protic solvents, namely by protonation of the nitrogen atom of the pyridine ring. 
The same explanation can justify the low fluorescence quantum yields obtained in 
chloroform, as the formation of hydrogen bonds between chloroform and proton acceptor 
molecules has been already described [22].  
The six compounds studied here are more fluorescent in polar solvents like 
dimethylformamide and dimethylsulfoxide, which is also a common behavior with the 
di(hetero)arylether derivatives of thieno[3,2-b]pyridines studied earlier [21]. Also, the 
substituent does not seem to have a significant influence in the fluorescence quantum yield 
values (Table SD1).  
For all compounds, significant red shifts are observed for emission in polar solvents (34-36 
nm between chloroform and dimethylsulfoxide for compounds 2a-c and 20-25 nm for 3a-c).  
In the absorption spectra, the red shifts are negligible (Table SD1), indicating that solvent 
relaxation after photoexcitation plays an important role, especially for compounds 2a-c. This 
indicates that the 1,3-arylurea substituent in the meta position relative to C-C bond contributes 
to increase the intramolecular charge transfer (ICT) character of the excited state.  
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The solvatochromic plots for compounds 2a–c and 3a–c, shown in Figures 4 and 5, are 
reasonably linear, the slope being larger for compound 2c. This predicts a higher ICT 
character of the excited state for this compound, maybe related with the position of the 
arylurea moiety together with the presence of a nitrile substituent.  
 
 
Figure 4. Solvatochromic plots (equation 4) for compounds 2a-c. Solvents: 1 - Dioxane; 2 - 
chloroform; 3 - ethyl acetate; 4 - dichloromethane; 5 - dimethylsulfoxide; 6 - N,N-dimethylformamide; 
7 - acetonitrile (values of  and n were obtained from ref. [23]). 
 
Figure 5. Solvatochromic plots (equation 4) for compounds 3a-c. Solvents: 1 - Dioxane; 2 - 
chloroform; 3 - ethyl acetate; 4 - dichloromethane; 5 - dimethylsulfoxide; 6 - N,N-dimethylformamide; 
7 - acetonitrile (values of  and n were obtained from ref. [23]). 
  12 
The slopes of the solvatochromic plots are much lower for compounds 3a-c, being similar 
for these three molecules. This indicates that the charge transfer character of the excited state 
is much lower for the arylureas in the ortho position relative to the thieno[3,2-b]pyridine-2-
carboxylate moiety. 
From ab initio molecular quantum chemistry calculations, obtained with Gaussian 09 
software
 
[24] and use of a 6-311+G(dp) basis set at the DFT (CAM-B3LYP/AUTO) level of 
theory [24,25] in gas phase, the cavity radius (R) and the ground state dipole moment (g) 
were determined for the six compounds (Table 2). The use of CAM-B3LYP functional was 
needed, as initial trials with the simpler B3LYP gave unrealistic underestimates of the 
HOMO-LUMO band gap (<500 nm). This is a known problem with B3LYP functional in the 
description of excited states with charge transfer character [25]. The optimized geometries of 
the ground state and the first excited state were obtained with a smaller basis set (3-21G+*) 
and are similar in the groups of compounds 2a-c and 3a-c (Figures 6 and 7). In the case of 
excited state calculations, a time dependent density functional method was used (TD-SCF 
DFT). In Table 1, the dihedral angle defined by the two molecular planes and the angles for 
the N-C-N and C-S-C chemical bonds (in the thienopyridine moiety) are indicated, evidencing 
notable differences in geometries between the two sets of compounds. Comparing the ground 
and excited state geometries, a small decrease (ca. 10º in 2a-c and 5º in 3a-c) of the dihedral 
angle is observed in the excited state (Table 1), together with a 2º increase in the C-S-C bond 
angle for all compounds. 
Table 1. Dihedral angle , N-C-N bond angle  and C-S-C bond angle  in the ground and first singlet 
excited state geometries for compounds 2a-c and 3a-c.  
Compound State Dihedral angle  N-C-N angle  C-S-C angle  
2a 
Ground -46.6º 112.6º 90.1º 
Excited -36.8º 112.8º 92.6º 
2b 
Ground -46.9º 112.5º 90.1º 
Excited -36.6º 112.8º 92.6º 
2c 
Ground -47.0º 112.5º 90.1º 
Excited -36.1º 112.7º 92.6º 
3a 
Ground 94.0º 112.3º 90.1º 
Excited 89.6º 112.5º 92.7º 
3b 
Ground 94.7º 112.2º 90.1º 
Excited 89.0º 112.5º 92.8º 
3c 
Ground 94.0º 112.2º 90.1º 
Excited 89.8º 112.4º 92.7º 
 
The directions of the calculated dipole moments in the ground and excited states are also 
indicated in Figures 6 and 7, evidencing an increase in magnitude and a change of direction in 
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the excited state dipole moment vector relative to the ground state one. This clearly indicates 
that the angle between the two dipole moment vectors cannot be neglected and must be 
considered in the solvatochromic plots (Bakhshiev’s equation (4)). Nevertheless, the change 
in the dipole moment direction is very small for compounds 2c and 3a. In the excited state, 
the dipole moment vectors for all compounds point to the side of the thienopyridine moiety. 
  
 
Figure 6. Optimized geometries of compounds 2a-c obtained by Gaussian 09 software (grey: C atoms; 
white: H atoms; red: O atoms; blue: N atoms; yellow: S atoms). Above: ground state; below: lowest 
excited singlet state. The arrows indicate the direction of the dipole moment. 
 
 
 
 
Figure 7. Optimized geometries of compounds 3a-c obtained by Gaussian 09 software (grey: C atoms; 
white: H atoms; red: O atoms; blue: N atoms; yellow: S atoms). Above: ground state; below: lowest 
excited singlet state. The arrows indicate the direction of the dipole moment. 
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The absolute value of the difference in the excited and ground state dipole moment vectors, 
estimated from the solvatochromic plots (Figures 4 and 5) and from molecular quantum 
mechanical calculations, is presented in Table 2, for each compound. The obtained values are 
very similar and, therefore, both methods point to the presence of a charge transfer 
mechanism in the excited state, more pronounced for compounds 2a-c. Compounds bearing 
an electron-donating group (-OCH3 in 2b) or an electron-withdrawing group (-CN in 2c) have 
a higher ICT character of the excited state than compound 2a. 
 
Table 2. Cavity radius (R), ground (g) and excited state (e) dipole moments obtained from 
theoretical calculations, and absolute value of the dipole moment difference ( ge 

), from quantum 
mechanical calculations and from the solvatochromic plots. 
Compound 
Cavity 
radius, R 
(Å) 
Ground state 
dipole moment, 
g (D) 
Excited state dipole 
moment, e (D), from 
theoretical 
calculations 
ge 

 (D) 
from theoretical 
calculations 
ge 

 (D) from 
solvatochromic 
plots 
2a 5.6 3.1 6.1  5.1 5.2 
2b 6.2 4.7 7.3  5.2 5.8 
2c 5.9 4.9 10.1 5.3 6.2 
3a 5.7 2.2 6.7 4.6 4.1 
3b 6.0 3.3 7.8 4.5 4.4 
3c 5.9 7.4 10.2 4.7 4.2 
 
 
Figure 8 displays the representation of electronic density difference between the lowest 
excited state and the ground state, for the lowest excited state optimized geometry (relaxed S1 
state). In general, it can be observed that electron density variations reside mostly on the 
thienopyridine-2-carboxylate moiety. This justifies that the compounds do not exhibit a 
noticeable influence of the arylurea substituent (-OCH3 or -CN) in their photophysical 
properties, namely in the fluorescence quantum yields. The more prominent features in Figure 
8 are an electron density transfer from the amino group linked to the thiophene ring and its 
sulfur atom to the nitrogen atom in the pyridine moiety and to the carboxylate group. In the π-
electron system, alternating increases and decreases of electronic density are observed. This 
confirms the ICT character of the first excited state of these compounds. 
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Figure 8. Representation of the electronic density difference for compounds 2a-c and 3a-c (optimized 
geometry for the lowest excited singlet state) at an iso level of 0.0004; green regions: loss of electronic 
density; red regions: enrichment of electronic density.  
 
 
The photophysical behavior of the six compounds shows that they can be considered as 
solvatochromic probes, especially compounds 2a-c. The sensitivity of the fluorescence 
emission to the fluorophore environment can be very useful when probing the 
location/behavior of these compounds in lipid membranes. 
 
3.3. Fluorescence studies in lipid membranes 
Fluorescence experiments of the six compounds incorporated in lipid membranes of several 
compositions were carried out. These lipid aggregates were composed either by neat 
phospholipids, or by phosphatidylcholines with cholesterol (Ch), for a better simulation of the 
biological membranes. In fact, the vesicles composed of 70% Egg-PC and 30% cholesterol 
(Egg-PC:Ch 7:3) are often used as models of the biological membranes [26,27]. 
Lipid membranes of neat DPPC (zwitterionic), DPPG (anionic), DODAB (cationic), Egg-PC 
(zwitterionic, composed of a phosphatidylcholine mixture), Egg-PC:Ch 7:3 and DPPC:Ch 
7:3, with incorporated compounds, were prepared and the fluorescence emission was 
monitored in both gel (below the main transition temperature, Tm) and liquid-crystalline 
(above Tm) phases of the phospholipids. At room temperature, the phospholipids DPPC, 
DODAB and DPPG are in ordered gel phase, where the hydrocarbon chains are fully 
extended and closely packed. The melting transition temperature of Egg-PC is very low [28] 
and this lipid is in the fluid liquid-crystalline phase at room temperature.  
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Fluorescence spectra of compounds incorporated in these lipid aggregates are presented in 
Figures 9 and 10. All the six compounds exhibit reasonable fluorescence emission when 
incorporated in lipid membranes, indicating that they are mainly located in the region of the 
lipid bilayer, as they are not fluorescent in alcohols or water. The maximum emission 
wavelengths in lipid membranes generally point to a hydrophobic medium for all compounds 
in these lipid aggregates, feeling an environment with polarity near dioxane or less polar than 
dioxane (Table 3). A slightly more hydrated environment is anticipated for the six compounds 
in DPPG vesicles at 25 ºC, considering the values of the maximum emission wavelengths. 
Fluorescence anisotropy (r) measurements can give relevant information about the location 
of the compounds in liposomes, as r increases with the rotational correlation time of the 
fluorescent molecule (and, thus, with the viscosity of the fluorophore environment) [29].  
Steady-state anisotropy relates to both the excited-state lifetime and the rotational correlation 
time of the fluorophore [29],          
     








c0
1
11
rr
      (7)  
where r0 is the fundamental anisotropy,  is the excited-state lifetime and c is the rotational 
correlation time. 
The fluorescence steady-state anisotropies of compounds 2a-c and 3a-c in lipid membranes 
are shown in Table 3. Anisotropy values in glycerol at room temperature were also 
determined for comparison.  
 
 
Figure 9. Normalized fluorescence spectra of compounds 2a and 2c (310-6 M) in lipid aggregates of 
Egg-PC, Egg-PC:Ch, DPPC and DPPC:Ch, at 25 ºC and 55 ºC. 
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Figure 10. Normalized fluorescence spectra of compounds 3a and 3c (310-6 M) in lipid aggregates of 
Egg-PC, Egg-PC:Ch, DPPC and DPPC:Ch, at 25 ºC and 55 ºC. 
 
 
Table 3. Steady-state fluorescence anisotropy (r) values and maximum emission wavelengths (em) for 
compounds 2a-c and 3a-c in lipid aggregates, below (25 ºC) and above (55 ºC) transition temperature of the 
lipids. Anisotropy values in glycerol at room temperature are also shown for comparison. 
Lipid 
T 
(ºC) 
2a 2b 2c 3a 3b 3c 
λem 
(nm) 
r 
λem 
(nm) 
r 
λem 
(nm) 
r 
λem 
(nm) 
r 
λem 
(nm) 
r 
λem 
(nm) 
r 
Egg-PC 25 452 0.221 449 0.205 451 0.210 449 0.248 451 0.249 449 0.240 
Egg-PC:Ch 
(7:3) 
25 443 0.197 440 0.187 443 0.190 446 0.228 446 0.221 445 0.231 
DPPC 
25 458 0.238 459 0.232 452 0.262 452 0.256 451 0.259 452 0.251 
55 443 0.168 441 0.167 443 0.175 449 0.163 448 0.122 449 0.180 
DPPC:Ch 
(7:3) 
25 434 0.172 438 0.175 439 0.192 450 0.199 449 0.171 450 0.194 
55 430 0.143 432 0.136 431 0.155 446 0.104 445 0.118 446 0.127 
DODAB 
25 457 0.229 457 0.200 453 0.243 448 0.230 456 0.251 451 0.247 
55 446 0.182 447 0.167 446 0.131 445 0.172 444 0.180 444 0.183 
DPPG 
25 467 0.230 466 0.223 466 0.250 461 0.233 464 0.226 457 0.209 
55 457 0.181 458 0.190 457 0.195 457 0.149 460 0.138 454 0.102 
Glycerol 25 474 0.325 465 0.295 469 0.308 464 0.330 462 0.327 459 0.324 
 
 
Steady-state fluorescence anisotropy results (Table 3) allow concluding that all compounds 
are mainly located in the inner region of the lipid membrane. The transition from the rigid gel 
phase to the fluid liquid-crystalline phase is clearly detected by a notable decrease in 
anisotropy at 55 ºC. An increase of the steady-state anisotropy is predicted from a decrease of 
the excited-state lifetime (equation 7). Upon rising temperature (from 25 ºC to 55 ºC), the 
excited-state lifetime decreases due to the increase of non-radiative deactivation pathways 
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(mainly the rate constant for internal conversion S1→S0). Instead of an expected rise in 
anisotropy (equation 7), a decrease is observed, which can only be attributed to a diminution 
of the rotational correlation time of the fluorophore, that arises from the decrease of 
membrane microviscosity upon changing from the gel to the liquid-crystalline phase.  
Fluorescence anisotropy values for the compounds incorporated in lipid membranes exhibit 
also a significant decrease when lipid aggregate fluidity increases by addition of cholesterol. 
Simultaneously, a blue shift in emission spectra (Figures 9 and 10 and Table 3) is observed 
when fluidity increases, either by phase transition to the liquid-crystalline phase or by 
cholesterol addition. These changes are much more pronounced for compounds 2a-c and may 
indicate a relocation of the fluorophores in a less hydrated environment. The decrease in local 
microviscosity can facilitate a deeper penetration of these molecules in lipid bilayers. The 
results obtained here point to a promising utility of the new diarylureas to monitor changes in 
fluidity of lipid membranes, especially compounds 2a-c. 
Microviscosity in hydrophobic domains of microheterogeneous systems has been measured 
using the widely known fluorescence probe 1,3-bis-(1-pyrenyl)propane (BPP) [30-35]. This 
probe can form intramolecular excimers and is highly sensitive to constraints imposed by its 
environment, reported by variations in the ratio between excimer and monomer emission 
intensities. The new diarylurea derivatives 2a-c and 3a-c showed in this work an interesting 
potential as fluidity probes for lipid membranes (especially 2a-c) through their intrinsic 
photophysical properties, rather than by the relative efficiency of a dynamic conformational 
change leading to an intramolecular pyrene excimer formation, as observed in BPP. However, 
further studies are needed to assess the utility of these new probes for microviscosity 
determinations of other types of microheterogeneous systems already studied using BPP, like 
micelles, liquid crystals, lipoproteins and synthetic polymers [30, 33-35]. 
 
4. Conclusions 
New six fluorescent 1,3-diarylureas in the thieno[3,2-b]pyridine series were prepared by a 
reaction of ortho and meta aminated Suzuki coupling products obtained by the formation of a 
C-C bond in the 6-position of the thieno[3,2-b]pyridine moiety, with different para-
substituted arylisocyanates (H, OMe or CN). 
The six compounds exhibit reasonable fluorescence quantum yields in several solvents and 
present a moderately solvent sensitive emission, but are not fluorescent in alcohols and water. 
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Compounds 2b and 2c with the arylurea moiety in the meta position and bearing a OMe or 
CN group, are the ones with better solvatochromic properties.   
Incorporation of compounds 2a-c and 3a-c in lipid membranes indicate that all compounds 
are deeply located in the hydrophobic region of the lipid bilayers, feeling the transition 
between the rigid gel phase and the liquid-crystalline phase. The results obtained point to a 
promising utility of these compounds to monitor changes in fluidity of lipid membranes, 
especially compounds 2a-c. Moreover, due to the potential biological activity of these new 
compounds, their interaction with lipid membranes is of particular interest. 
 
Supplementary Data 
Table SD1. Maximum absorption (abs) and emission wavelengths (em), molar absorption 
coefficients () and fluorescence quantum yields (F) for compounds 2a-c and 3a-c in several 
solvents. 
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